178 related articles for article (PubMed ID: 34154922)
1. Progression of vertebral bone disease in mucopolysaccharidosis VII dogs from birth to skeletal maturity.
Peck SH; Lau YK; Kang JL; Lin M; Arginteanu T; Matalon DR; Bendigo JR; O'Donnell P; Haskins ME; Casal ML; Smith LJ
Mol Genet Metab; 2021 Aug; 133(4):378-385. PubMed ID: 34154922
[TBL] [Abstract][Full Text] [Related]
2. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.
Peck SH; Tobias JW; Shore EM; Malhotra NR; Haskins ME; Casal ML; Smith LJ
Bone; 2019 Nov; 128():115042. PubMed ID: 31442675
[TBL] [Abstract][Full Text] [Related]
4. Epiphyseal cartilage canal architecture and extracellular matrix remodeling in mucopolysaccharidosis VII dogs at the onset of postnatal growth.
Jiang Z; Johnson CP; Nykänen O; Nissi M; Lau YK; Wu M; Casal ML; Smith LJ
Connect Tissue Res; 2021 Nov; 62(6):698-708. PubMed ID: 33334202
[No Abstract] [Full Text] [Related]
5. Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs.
Lau YK; Peck SH; Arginteanu T; Wu M; Lin M; Shore EM; Klein PS; Casal ML; Smith LJ
Bone; 2022 Jan; 154():116237. PubMed ID: 34695616
[TBL] [Abstract][Full Text] [Related]
6. Delayed development of ossification centers in the tibia of prenatal and early postnatal MPS VII mice.
Jiang Z; Derrick-Roberts ALK; Jackson MR; Rossouw C; Pyragius CE; Xian C; Fletcher J; Byers S
Mol Genet Metab; 2018 Jun; 124(2):135-142. PubMed ID: 29747998
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.
Smith LJ; Baldo G; Wu S; Liu Y; Whyte MP; Giugliani R; Elliott DM; Haskins ME; Ponder KP
Mol Genet Metab; 2012 Sep; 107(1-2):153-60. PubMed ID: 22513347
[TBL] [Abstract][Full Text] [Related]
8. Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs.
Chiaro JA; Baron MD; Del Alcazar CM; O'Donnell P; Shore EM; Elliott DM; Ponder KP; Haskins ME; Smith LJ
Bone; 2013 Jul; 55(1):78-83. PubMed ID: 23563357
[TBL] [Abstract][Full Text] [Related]
9. Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs.
Smith LJ; Martin JT; O'Donnell P; Wang P; Elliott DM; Haskins ME; Ponder KP
Mol Genet Metab; 2012 Sep; 107(1-2):145-52. PubMed ID: 22510705
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural analysis of different skeletal cell types in mucopolysaccharidosis dogs at the onset of postnatal growth.
Jiang Z; Lau YK; Wu M; Casal ML; Smith LJ
J Anat; 2021 Feb; 238(2):416-425. PubMed ID: 32895948
[TBL] [Abstract][Full Text] [Related]
11. Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VII.
Smith LJ; Martin JT; Szczesny SE; Ponder KP; Haskins ME; Elliott DM
J Orthop Res; 2010 May; 28(5):616-22. PubMed ID: 19918911
[TBL] [Abstract][Full Text] [Related]
12. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
[TBL] [Abstract][Full Text] [Related]
13. The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade.
Bigg PW; Sleeper MM; O'Donnell PA; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Nov; 110(3):311-8. PubMed ID: 23860311
[TBL] [Abstract][Full Text] [Related]
14. A novel GUSB mutation in Brazilian terriers with severe skeletal abnormalities defines the disease as mucopolysaccharidosis VII.
Hytönen MK; Arumilli M; Lappalainen AK; Kallio H; Snellman M; Sainio K; Lohi H
PLoS One; 2012; 7(7):e40281. PubMed ID: 22815736
[TBL] [Abstract][Full Text] [Related]
15. Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.
Kantaputra PN; Smith LJ; Casal ML; Kuptanon C; Chang YC; Nampoothiri S; Paiyarom A; Veerasakulwong T; Trachoo O; Ketudat Cairns JR; Chinadet W; Tanpaiboon P
Am J Med Genet A; 2019 Mar; 179(3):486-493. PubMed ID: 30653816
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
[TBL] [Abstract][Full Text] [Related]
17. Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy.
Herati RS; Knox VW; O'Donnell P; D'Angelo M; Haskins ME; Ponder KP
Mol Genet Metab; 2008 Nov; 95(3):142-51. PubMed ID: 18707908
[TBL] [Abstract][Full Text] [Related]
18. Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII.
Macsai CE; Derrick-Roberts AL; Ding X; Zarrinkalam KH; McIntyre C; Anderson PH; Anson DS; Byers S
Mol Genet Metab; 2012 Jun; 106(2):202-13. PubMed ID: 22525091
[TBL] [Abstract][Full Text] [Related]
19. The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.
Xing EM; Knox VW; O'Donnell PA; Sikura T; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Jun; 109(2):183-93. PubMed ID: 23628461
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effects of enzyme replacement therapy on skeletal disease progression in mucopolysaccharidosis VII dogs.
Gawri R; Lau YK; Lin G; Shetye SS; Zhang C; Jiang Z; Abdoun K; Scanzello CR; Jo SY; Mai W; Dodge GR; Casal ML; Smith LJ
Mol Ther Methods Clin Dev; 2023 Mar; 28():12-26. PubMed ID: 36570425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
